🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

CORRECTED-Chinese firms among bidders for Australia's I-MED, valued at over $765 mln-sources

Published 01/11/2017, 07:15 pm
Updated 01/11/2017, 07:20 pm
© Reuters.  CORRECTED-Chinese firms among bidders for Australia's I-MED, valued at over $765 mln-sources
MS
-
000766
-
0801
-

(Corrects alert and headline to say $765 mln, not $765 bln)

* Tonghua Golden-Horse, Golden Meditech among bidders -sources

* Ontario Teachers', Permira also to bid -sources

* Binding bids due by end of this month

* Deal to value I-MED around 10-12 times its 2017 EBITDA

By Carol Zhong and Paulina Duran

HONG KONG/SYDNEY, Nov 1 (Reuters) - Two Chinese healthcare firms are among investors seeking to buy Australia's I-MED Radiology Network in a deal that could value the X-ray provider at more than A$1 billion ($765 million), people with knowledge of the matter said.

Shenzhen-listed Tonghua Golden-Horse Pharmaceutical Industry 000766.SZ and Hong Kong-listed Golden Meditech Holdings 0801.HK , are likely to participate in a second round of bidding, three people told Reuters.

The Ontario Teachers' Pension Plan, Canada's third-largest public pension plan, and London-based private equity firm Permira, are also expected to submit separate bids, two of the people said.

Binding bids are due by end of this month.

Chinese interest in Australia's biggest X-ray provider comes as Beijing strives to overhaul its healthcare sector and boost the competitiveness of the domestic industry in overseas markets, with acquisitions one of the key planks for that drive.

With nearly 200 clinics cross Australia, I-MED has 18 percent of the nation's diagnostic imaging services market, which is partially subsidised by the government, according to a September report by researcher IBISWorld.

I-MED's owner, Swedish private equity firm EQT Holdings, has hired Morgan Stanley (NYSE:MS) and Rothschild to manage the sale process, the people said, who declined to be identified as the deal process is not public.

Representatives from Tonghua Golden-Horse, Golden Meditech, I-MED, Ontario Teacher's Pension Plan and Rothschild did not respond to Reuters requests for comment. EQT, Morgan Stanley and Permira declined to comment.

I-MED booked A$608 million in sales and A$100 million in earnings before interest, tax, depreciation and amortization (EBITDA) in its 2016 financial year, according to EQT's website.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.